참고문헌
- Cairns SR, Scholefield J (2002). Guidelines for colorectal cancer screening in high risk groups. Gut, 51, 1-2. https://doi.org/10.1136/gut.51.1.e1
- Cairns SR, Scholefield JH, Steele RJ, et al (2010). Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups. Gut, 59, 666-89. https://doi.org/10.1136/gut.2009.179804
- Castiglione G, Zappa M, Grazzini G, et al (1996). Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer. British J Cancer, 74, 141. https://doi.org/10.1038/bjc.1996.329
- Compton CC, Fielding LP, Burgart LJ, et al (2000). Prognostic factors in colorectal cancer. Arch Pathol Lab Med, 124, 979-94.
- Ferrat E, Le Breton J, Veerabudun K, et al (2013). Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test. Br J Cancer, 109, 1437-44. https://doi.org/10.1038/bjc.2013.476
- Frazier AL, Colditz GA, Fuchs CS, et al (2000). Costeffectiveness of screening for colorectal cancer in the general population. JAMA, 284, 1954-61. https://doi.org/10.1001/jama.284.15.1954
- Hardcastle JD, Chamberlain JO, Robinson MH, et al (1996). Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet, 348, 1472-7. https://doi.org/10.1016/S0140-6736(96)03386-7
- Hewitson P, Glasziou P, Watson E, et al (2008). Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 103, 1541-9. https://doi.org/10.1111/j.1572-0241.2008.01875.x
- Kronborg O, Fenger C, Olsen J, et al (1996). Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet, 348, 1467-71. https://doi.org/10.1016/S0140-6736(96)03430-7
- Launoy GD, Bertrand HJ, Berchi C, et al (2005). Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Int J Cancer, 115, 493-6. https://doi.org/10.1002/ijc.20921
- Leuraud K, Jezewski-Serra D, Viguier J, et al (2013). Colorectal cancer screening by guaiac faecal occult blood test in France:Evaluation of the programme two years after launching. Cancer Epidemiol, 37, 959-67. https://doi.org/10.1016/j.canep.2013.07.008
- Logan RF, Patnick J, Nickerson C, et al (2012). Outcomes of the bowel cancer screening programme (BCSP) in England after the first 1 million tests. Gut, 61, 1439-46. https://doi.org/10.1136/gutjnl-2011-300843
- Meester RG, Doubeni CA, Lansdorp-Vogelaar I, et al (2015). Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol, 25, 208-13. https://doi.org/10.1016/j.annepidem.2014.11.011
- Ministry of Health, Malaysia (2007). National cancer registry report: malaysia cancer statistics - data and Figure.
- Moss S, Campbell C, Melia J, et al (2011). Performance measures in three rounds of the English bowel cancer screening pilot. Gut, 2010, 236430.
- O'Connell JB, Maggard MA, Ko CY (2004). Colon cancer survival rates with the new american joint committee on cancer sixth edition staging. J Natl Cancer Inst, 96, 1420-5. https://doi.org/10.1093/jnci/djh275
- Oono Y, Iriguchi Y, Doi Y, et al (2010). A retrospective study of immunochemical fecal occult blood testing for colorectal cancer detection. Clinica Chimica Acta, 411, 802-5. https://doi.org/10.1016/j.cca.2010.02.057
- Steele R, Kostourou I, McClements P, et al (2010). Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme. J Med Screen, 17, 68-74. https://doi.org/10.1258/jms.2010.009120
- Winawer S, Fletcher R, Rex D, et al (2003). Colorectal cancer screening and surveillance: clinical guidelines and rationaleupdate based on new evidence. Gastroenterol, 124, 544-60. https://doi.org/10.1053/gast.2003.50044
피인용 문헌
- The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta-analysis pp.2050-6414, 2019, https://doi.org/10.1177/2050640619828185